...
首页> 外文期刊>Cell cycle >p21WAF1/CIP1 regulates the p300 sumoylation motif CRD1 through a C-terminal domain independently of cyclin/CDK binding.
【24h】

p21WAF1/CIP1 regulates the p300 sumoylation motif CRD1 through a C-terminal domain independently of cyclin/CDK binding.

机译:p21WAF1 / CIP1通过C末端域独立于细胞周期蛋白/ CDK结合调节p300磺酰化基序CRD1。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Although best known for its ability to inhibit Cyclin/Cdk complexes and the replication protein PCNA, p21(WAF1/CIP1) is a multifunctional protein that interacts with many cellular binding partners, including a number of transcriptional regulators. Previously, we characterized p21 derepression of the p300 sumoylation-dependent transcriptional repression domain, CRD1. Such repression domains are at least partially dependent upon recruitment of histone deacetylase (HDAC) complexes but the mechanism through which p21 selectively disrupts CRD1 activity remains unknown. Here, we demonstrate that distinct motifs in the C-terminus of p21 are required for regulation of p300 CRD1 function and that this effect does not correlate with Cyclin or PCNA binding. Through the creation of N-terminal glutathione-s-transferase fusion proteins, which also overcome the problems of instability that result from many p21 mutations, we investigated p21 binding to HDACs. Although p21 binds both Class I and Class II HDACs in vitro, only weak association with HDAC1 and 2 is seen in cells. Mutation of the p21 PCNA binding domain significantly increases this interaction suggesting that binding is mutually exclusive and only naturally occurs under certain conditions. Binding of HDACs also failed to correlate with CRD1 inducibility, suggesting that p21 targets other transcriptional repression complexes to mediate this effect.
机译:尽管p21(WAF1 / CIP1)以其抑制Cyclin / Cdk复合物和复制蛋白PCNA的能力而著称,但它是一种多功能蛋白,可与许多细胞结合伴侣(包括许多转录调节因子)相互作用。以前,我们表征了p300依赖于sum300的转录抑制域CRD1的p21抑制。此类阻抑域至少部分取决于组蛋白脱乙酰基酶(HDAC)复合物的募集,但p21选择性破坏CRD1活性的机制尚不清楚。在这里,我们证明p21 C末端的不同基序是调节p300 CRD1功能所必需的,并且这种作用与细胞周期蛋白或PCNA的结合无关。通过创建N末端谷胱甘肽S-转移酶融合蛋白,该蛋白也克服了许多p21突变导致的不稳定问题,我们研究了p21与HDAC的结合。尽管p21在体外结合I类和II类HDAC,但在细胞中仅发现与HDAC1和2的弱关联。 p21 PCNA结合域的突变显着增加了这种相互作用,表明结合是互斥的,并且仅在某些条件下自然发生。 HDAC的绑定也未能与CRD1诱导性相关,表明p21靶向其他转录抑制复合体来介导此作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号